Roche Holding AG (RHHBY)
52.51
+0.26
(+0.50%)
USD |
OTCM |
Oct 05, 16:00
Roche Market Cap : 289.89B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 289.89B |
| October 02, 2026 | 288.45B |
| October 01, 2026 | 289.00B |
| September 30, 2026 | 286.41B |
| September 29, 2026 | 288.45B |
| September 28, 2026 | 294.63B |
| September 25, 2026 | 300.60B |
| September 24, 2026 | 302.53B |
| September 23, 2026 | 303.96B |
| September 22, 2026 | 307.28B |
| September 21, 2026 | 305.29B |
| September 18, 2026 | 298.94B |
| September 17, 2026 | 301.59B |
| September 16, 2026 | 304.46B |
| September 15, 2026 | 303.33B |
| September 14, 2026 | 302.53B |
| September 11, 2026 | 291.21B |
| September 10, 2026 | 293.64B |
| September 09, 2026 | 294.69B |
| September 08, 2026 | 298.50B |
| September 04, 2026 | 303.44B |
| September 03, 2026 | 304.85B |
| September 02, 2026 | 297.17B |
| September 01, 2026 | 293.09B |
| August 31, 2026 | 296.46B |
| Date | Value |
|---|---|
| August 28, 2026 | 304.68B |
| August 27, 2026 | 311.31B |
| August 26, 2026 | 314.07B |
| August 25, 2026 | 322.79B |
| August 24, 2026 | 317.27B |
| August 21, 2026 | 320.75B |
| August 20, 2026 | 316.05B |
| August 19, 2026 | 321.30B |
| August 18, 2026 | 306.53B |
| August 17, 2026 | 301.48B |
| August 14, 2026 | 300.98B |
| August 13, 2026 | 306.34B |
| August 12, 2026 | 311.97B |
| August 11, 2026 | 312.58B |
| August 10, 2026 | 317.05B |
| August 07, 2026 | 316.11B |
| August 06, 2026 | 310.09B |
| August 05, 2026 | 311.42B |
| August 04, 2026 | 305.95B |
| August 03, 2026 | 304.07B |
| July 31, 2026 | 301.81B |
| July 30, 2026 | 305.12B |
| July 29, 2026 | 303.47B |
| July 28, 2026 | 312.02B |
| July 27, 2026 | 302.36B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 257.66B |
| AstraZeneca PLC | 491.86B |
| GSK Plc | 94.25B |
| Johnson & Johnson | 613.57B |
| Eli Lilly & Co. | 1.090T |
Market Cap Related Metrics
| PE Ratio | 21.72 |
| PS Ratio | 4.402 |
| PEG Ratio | 0.7289 |
| Price to Free Cash Flow | 20.65 |
| Price | 52.51 |
| Earnings Yield | 4.60% |
| PEGY Ratio | 0.6632 |
| Operating PE Ratio | 14.36 |
| Normalized PE Ratio | 18.20 |